InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: stoneroad post# 221910

Tuesday, 06/02/2015 4:49:00 PM

Tuesday, June 02, 2015 4:49:00 PM

Post# of 346050
I don't know but what I do know is PEregrine probably has the most leverage heading into these partnering opportunities and BMGF has some sponsorship there as well

If BMGF sponsored those Keystone Symposia events March of 2014 then they (BMGF) may appear again on Peregrines side

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News